A RANDOMIZED CLINICAL STUDY TO EVALUATE THE EFFECTIVENESS OF DHANWANTARA TAILA AS UTTARA BASTI AND ORAL ADMINISTRATION IN THE MANAGEMENT OF VATASHTHEELA WITH SPECIAL REFERENCE TO BENIGN PROSTATE HYPERPLASIA

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Subject diagnosed as Benign Prostatic Hyperplasia by clinical and investigative methods will
•be selected.
•Patients having IPSS Score 7- 20 should be included.
•In USG findings, patients having Prostate gland weight more than 40 gm and Residual Urine
•Volume above 30 ml should be included.13
•In uroflometry Qmax 3- 20 ml/s should be included.

•Patients with IPSS (International Prostate Symptom Score) above 20 (severe)
•Patients having other systemic pathology like Tuberculosis, Renal Failure, Uncontrolled
•Diabetes Mellitus And Uncontrolled Hypertension Etc..
•Patients having other urinarysystem pathology like severe Urinary tract
•infections, Nephrolithiasis, Urethral Stricture, Prostatitis
•Patients suffering from Prostatic malignancy
•Patients having congenital deformity of urogenital tract
•HIV and HBsAg positive patients
•Patients having PSA value above normal (above 10 ng/ml )should be excluded.

发起方